Nomograms incorporating primary tumor response at mid‐radiotherapy to predict survival in locoregionally advanced nasopharyngeal carcinoma

Author:

Liu Xixi1ORCID,Huang Jing1,Qin You1,Zhang Zhanjie1,Wu Bian1,Yang Kunyu1ORCID

Affiliation:

1. Cancer Center, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

Abstract

AbstractBackgroundA nomogram that incorporates tumor response at mid‐radiotherapy (mid‐RT) to predict the prognosis of locoregionally advanced nasopharyngeal carcinoma (LA‐NPC) has not been established.MethodsThis study retrospectively reviewed 583 patients with LA‐NPC who underwent magnetic resonance imaging scans at mid‐RT (the fourth week of RT) between 2015 and 2019.ResultsPrimary tumor (PT) response at mid‐RT was found to predict disease‐free survival (DFS) and overall survival (OS). Independent factors from multivariable analysis to predict DFS and OS were assembled into nomograms with (nomograms Amid‐RT and Bmid‐RT) or without (nomograms Abaseline and Bbaseline) PT response. Internal validation revealed good performance of these nomograms in discrimination: C‐statistics = 0.761 for nomogram Amid‐RT and 0.809 for nomogram Bmid‐RT, which showed better discrimination performance than (C‐statistics: 0.755) nomogram Abaseline and (C‐statistics: 0.798) nomogram Bbaseline (Z‐statistic = 2.476, p < 0.05; Z‐statistic = 1.971, p < 0.05).ConclusionThe nomograms based on PT response at mid‐RT showed favorable predictive accuracy for DFS and OS in patients with LA‐NPC.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Otorhinolaryngology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3